UBE3A antisense oligonucleotide therapy (Q-State Biosciences)

N/A

Report date: 2025/01/26 16:35:33
NME

Base Information

Drug NameUBE3A antisense oligonucleotide therapy (Q-State Biosciences)
Drug Alias NameUBE3A gene inhibitor (Q-State Biosciences)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionUbiquitin-like modifier-activating enzyme 3A inhibitors
TargetsUbiquitin-like modifier-activating enzyme 3A
Therapy Area/IndicationsChromosome Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuiver Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesQuiver Bioscience Inc
Inactive CompaniesN/A
Active IndicationsChromosome Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A